Background: The ACP1 gene, encoding a low-molecular-weight phosphotyrosine phosphatase (LMW-PTP), has been suggested as a common genetic factor of several human diseases, including inflammatory and autoimmune diseases, favism and tumors. For this reason, the ACP1 enzyme has been investigated by case-control studies for decades. Initially based on protein electrophoresis, the ACP1 phenotype is now determined by DNA-based techniques. Methods: Here, we report a rapid optimized method which employs HRMA for ACP1 polymorphism identification, a molecular approach that we used to screen 80 healthy Italian subjects. Results: HRMA proved particularly suitable for detecting ACP1 genotypes. In fact, HRMA results were 100\% concordant with direct sequencing. In addition, ACP1 genotype frequency in the Italian population was in accordance with the literature {[4\% (*A/A), 36\% (*A/B), 4\% (*A/C), 50\% (*B/B), 6\% (*B/C)]. Conclusions: HRMA was found to be a simple, rapid, sensitive and low cost method potentially useful in research and diagnostic laboratories. Finally, use of small amplicons for the set-up allowed us a better optimization of HRMA. For this reason, we present such an approach as small amplicons high resolution melting analysis (SA-HRMA). Finally, ACP1 genotype frequency in the Italian population reported in this study may contribute to a better interpretation of ACP1 allelic frequency variation. (c) 2012 Elsevier B.V. All rights reserved.}
Minucci, A., Canu, G., Gentile, L., Zuppi, C., Giardina, B., Capoluongo, E. D., Small Amplicons High Resolution Melting Analysis (SA-HRMA) allows successful genotyping of acid phosphatase 1 (ACP1) polymorphisms in the Italian population, <<CLINICA CHIMICA ACTA>>, 2013; 416 (Febbraio): 86-91. [doi:10.1016/j.cca.2012.11.023] [http://hdl.handle.net/10807/43430]
Small Amplicons High Resolution Melting Analysis (SA-HRMA) allows successful genotyping of acid phosphatase 1 (ACP1) polymorphisms in the Italian population
Minucci, Angelo;Canu, Giulia;Zuppi, Cecilia;Giardina, Bruno;Capoluongo, Ettore Domenico
2013
Abstract
Background: The ACP1 gene, encoding a low-molecular-weight phosphotyrosine phosphatase (LMW-PTP), has been suggested as a common genetic factor of several human diseases, including inflammatory and autoimmune diseases, favism and tumors. For this reason, the ACP1 enzyme has been investigated by case-control studies for decades. Initially based on protein electrophoresis, the ACP1 phenotype is now determined by DNA-based techniques. Methods: Here, we report a rapid optimized method which employs HRMA for ACP1 polymorphism identification, a molecular approach that we used to screen 80 healthy Italian subjects. Results: HRMA proved particularly suitable for detecting ACP1 genotypes. In fact, HRMA results were 100\% concordant with direct sequencing. In addition, ACP1 genotype frequency in the Italian population was in accordance with the literature {[4\% (*A/A), 36\% (*A/B), 4\% (*A/C), 50\% (*B/B), 6\% (*B/C)]. Conclusions: HRMA was found to be a simple, rapid, sensitive and low cost method potentially useful in research and diagnostic laboratories. Finally, use of small amplicons for the set-up allowed us a better optimization of HRMA. For this reason, we present such an approach as small amplicons high resolution melting analysis (SA-HRMA). Finally, ACP1 genotype frequency in the Italian population reported in this study may contribute to a better interpretation of ACP1 allelic frequency variation. (c) 2012 Elsevier B.V. All rights reserved.}I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.